These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 283276)

  • 1. A radioimmunometric antibody-binding assay for evaluation of xenoantisera to melanoma-associated antigens.
    McCabe RP; Quaranta V; Frugis L; Ferrone S; Reisfeld RA
    J Natl Cancer Inst; 1979 Mar; 62(3):455-63. PubMed ID: 283276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera.
    Imai K; Ferrone S
    Cancer Res; 1980 Jul; 40(7):2252-6. PubMed ID: 6966965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human melanoma associated antigens: a solid-phase assay for detection of specific antibody.
    Morgan AC; Galloway DR; Wilson BS; Reisfeld RA
    J Immunol Methods; 1980; 39(3):233-46. PubMed ID: 7462650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-A antibody-binding TPAAB) technique for detection of tumor-associated membrane antigen (TAMA) of Lewis lung carcinoma.
    Veltri RW; McKolanis JR; Rockoff SD; McIntire KR
    Int J Cancer; 1980 Jan; 25(1):141-5. PubMed ID: 7399741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.
    Galloway DR; McCabe RP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1981 Jan; 126(1):62-6. PubMed ID: 7451981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of tumour associated antigen in eluates from protein A columns used for ex vivo immunoadsorption of plasma from melanoma patients by radioimmunoassay.
    Gupta RK; Leitch AM; Morton DL
    Clin Exp Immunol; 1983 Sep; 53(3):589-99. PubMed ID: 6193912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature of antigens and antibodies in immune complexes isolated by staphylococcal protein A from plasma of melanoma patients.
    Gupta RK; Leitch AM; Morton DL
    Cancer Immunol Immunother; 1983; 16(1):40-7. PubMed ID: 6556950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of heteroantisera to cells from human malignant effusions by immunofluorescence and protein A binding.
    Birchall JP; Owen JJ; Owen BS
    Br J Cancer; 1977 Dec; 36(6):730-42. PubMed ID: 339939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association of serologically detectable human melanoma-associated antigens with beta 2 microglobulin: serologic and immunochemical evidence.
    McCabe RP; Indiveri F; Galloway DR; Ferrone S; Reisfeld RA
    J Natl Cancer Inst; 1980 Oct; 65(4):703-7. PubMed ID: 6158590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification and immunologic evaluation of human melnoma-associated antigens.
    McCabe RP; Ferrone S; Pellegrino MA; Kern DH; Holmes EC; Reisfeld RA
    J Natl Cancer Inst; 1978 Apr; 60(4):773-7. PubMed ID: 75978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
    Saxton RE; Mann BD; Morton DL; Burk MW
    Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera.
    Wilson BS; Kay NE; Imai K; Ferrone S
    Cancer Immunol Immunother; 1982; 13(1):69-74. PubMed ID: 7159874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.
    Houghton AN; Taormina MC; Ikeda H; Watanabe T; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4260-4. PubMed ID: 6933476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microassay using radioiodinated protein A from Staphylococcus aureus for antibodies bound to cell surface antigens of adherent tumor cells.
    Zeltzer PM; Seeger RC
    J Immunol Methods; 1977; 17(1-2):163-75. PubMed ID: 903615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of DR xenoantisera: use for detection of serum DR antigens.
    Wilson BS; Indiveri F; Pellegrino MA; Ferrone S
    J Immunol; 1979 May; 122(5):1967-71. PubMed ID: 376728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of antisera with specificity for malignant melanoma and human fetal skin.
    Fritze D; Kern DH; Drogemuller CR; Pilch YH
    Cancer Res; 1976 Feb; 36(2 Pt 1):458-66. PubMed ID: 56991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of humoral and cell-mediated immunity in human melanoma.
    Mukherji B; Nathanson L; Clark DA
    Yale J Biol Med; 1973 Dec; 46(5):681-92. PubMed ID: 4130586
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunofluorescent studies of the serologic reactivity of patients with malignant melanoma against tumor-associated cytoplasmic antigens.
    Wood GW; Barth RF
    J Natl Cancer Inst; 1974 Aug; 53(2):309-16. PubMed ID: 4602060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.